Evidence map›Paper›PMID 38059627›Full record

ArticleMicrobiology spectrum2024

Yonggen Jia, Zhangchun Guan, Chenghua Liu, Minjun Huang, Jingjing Li, Jiannan Feng, Beifen Shen, Guang Yang

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Anti-staphylococcal activity of the auranofin-analogous PEtFrontiers in cellular and infection microbiology · 2026
    Article
  9. Virulence · 2025
    Article
  10. Article
  11. Article
  12. Whole Genome Sequence Analysis of Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2025
    Article
  13. Article
  14. Integrated genomic and proteomic analysis of the mouse-adaptedCurrent research in microbial sciences · 2025
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yonggen Jia *Beijing Institute of Tropical Medicine, Beijing Friendship Hospital, Capital Medical University , Beijing, China.ORCID 0000-0002-5990-7817
Zhangchun Guan *Beijing Institute of Pharmacology and Toxicology , Beijing, China.
Chenghua LiuBeijing Institute of Pharmacology and Toxicology , Beijing, China.
Minjun HuangBeijing Institute of Tropical Medicine, Beijing Friendship Hospital, Capital Medical University , Beijing, China.
Jingjing LiBeijing Institute of Tropical Medicine, Beijing Friendship Hospital, Capital Medical University , Beijing, China.
Jiannan FengBeijing Institute of Pharmacology and Toxicology , Beijing, China.
Beifen ShenBeijing Institute of Pharmacology and Toxicology , Beijing, China.
Guang YangBeijing Institute of Tropical Medicine, Beijing Friendship Hospital, Capital Medical University , Beijing, China.ORCID 0000-0003-4240-8197
Capital Medical University · CNXuzhou Medical College · CN

Funding

MOST | National Natural Science Foundation of China (NSFC) 81871618MOST | National Natural Science Foundation of China (NSFC) 81971953
6 · The paper itself

Abstract

importance

Indexed as

Staphylococcal InfectionsStaphylococcus aureusErbB ReceptorsHemolysin ProteinsHumansInflammationSkinErbB ReceptorsHemolysin ProteinsADAM17EGFRskin inflammationsphingomyelinaseStaphylococcus aureusβ-hemolysin

Identifiers

PMID38059627
PMCPMC10783061
OpenAlexW4389435377

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.